Carolinas Wealth Consulting LLC Sells 129 Shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Carolinas Wealth Consulting LLC decreased its position in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 27.8% during the 2nd quarter, according to its most recent disclosure with the SEC. The fund owned 335 shares of the company’s stock after selling 129 shares during the period. Carolinas Wealth Consulting LLC’s holdings in GE HealthCare Technologies were worth $26,000 as of its most recent SEC filing.

A number of other hedge funds have also recently modified their holdings of the company. Hsbc Holdings PLC increased its stake in shares of GE HealthCare Technologies by 17.1% during the second quarter. Hsbc Holdings PLC now owns 752,488 shares of the company’s stock valued at $58,720,000 after buying an additional 109,951 shares during the period. First Washington CORP lifted its position in shares of GE HealthCare Technologies by 29.4% in the 2nd quarter. First Washington CORP now owns 89,122 shares of the company’s stock worth $6,944,000 after purchasing an additional 20,250 shares during the period. Elo Mutual Pension Insurance Co boosted its stake in shares of GE HealthCare Technologies by 4.1% during the 2nd quarter. Elo Mutual Pension Insurance Co now owns 38,905 shares of the company’s stock valued at $3,031,000 after purchasing an additional 1,525 shares in the last quarter. Blair William & Co. IL increased its position in shares of GE HealthCare Technologies by 0.3% during the second quarter. Blair William & Co. IL now owns 110,258 shares of the company’s stock valued at $8,591,000 after buying an additional 294 shares during the period. Finally, Elkhorn Partners Limited Partnership bought a new position in GE HealthCare Technologies in the second quarter worth about $31,000. Hedge funds and other institutional investors own 82.06% of the company’s stock.

Insider Buying and Selling

In other GE HealthCare Technologies news, CEO Thomas J. Westrick sold 2,750 shares of the business’s stock in a transaction on Wednesday, August 7th. The shares were sold at an average price of $80.78, for a total transaction of $222,145.00. Following the completion of the sale, the chief executive officer now directly owns 17,509 shares in the company, valued at approximately $1,414,377.02. The sale was disclosed in a document filed with the SEC, which is available through this link. 0.27% of the stock is currently owned by corporate insiders.

Analyst Ratings Changes

GEHC has been the topic of several research reports. JPMorgan Chase & Co. started coverage on GE HealthCare Technologies in a research report on Monday, September 9th. They set a “neutral” rating and a $90.00 price objective on the stock. Stifel Nicolaus initiated coverage on GE HealthCare Technologies in a report on Tuesday, August 6th. They issued a “buy” rating and a $100.00 price objective for the company. The Goldman Sachs Group initiated coverage on GE HealthCare Technologies in a research report on Thursday, May 30th. They set a “neutral” rating and a $87.00 price objective for the company. Redburn Atlantic upgraded shares of GE HealthCare Technologies to a “strong-buy” rating in a research note on Thursday, August 1st. Finally, BTIG Research raised shares of GE HealthCare Technologies from a “neutral” rating to a “buy” rating and set a $100.00 price objective on the stock in a research note on Wednesday. Six investment analysts have rated the stock with a hold rating, seven have given a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat, GE HealthCare Technologies presently has an average rating of “Moderate Buy” and a consensus price target of $95.00.

GE HealthCare Technologies Stock Performance

GEHC stock opened at $90.62 on Friday. The stock’s 50 day simple moving average is $83.64 and its 200 day simple moving average is $83.31. The company has a current ratio of 1.06, a quick ratio of 0.82 and a debt-to-equity ratio of 1.05. GE HealthCare Technologies Inc. has a 12-month low of $62.35 and a 12-month high of $94.50. The stock has a market capitalization of $41.36 billion, a PE ratio of 26.50, a price-to-earnings-growth ratio of 3.26 and a beta of 1.17.

GE HealthCare Technologies (NASDAQ:GEHC) last released its quarterly earnings data on Wednesday, July 31st. The company reported $1.00 EPS for the quarter, beating the consensus estimate of $0.98 by $0.02. GE HealthCare Technologies had a return on equity of 25.26% and a net margin of 8.10%. The company had revenue of $4.84 billion for the quarter, compared to analysts’ expectations of $4.88 billion. During the same period last year, the firm posted $0.92 earnings per share. GE HealthCare Technologies’s revenue was up .5% compared to the same quarter last year. As a group, research analysts forecast that GE HealthCare Technologies Inc. will post 4.26 earnings per share for the current fiscal year.

GE HealthCare Technologies Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Thursday, August 15th. Investors of record on Friday, July 19th were given a dividend of $0.03 per share. The ex-dividend date of this dividend was Friday, July 19th. This represents a $0.12 dividend on an annualized basis and a yield of 0.13%. GE HealthCare Technologies’s dividend payout ratio (DPR) is 3.51%.

GE HealthCare Technologies Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.